Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Despite the top-heaviness of the spine market, three mid-tier spine players are growing at an impressive rate.
NanoHive is exploring the development of a Hive™ Soft Titanium® Spinal Interbody “Smart Implant” with data collection and bone stimulation capability.
Despite the top-heaviness of the spine market, three mid-tier spine players are growing at an impressive rate.
HyperFlex Bunion Correction realigns and stabilizes the 1st and 2nd metatarsals using a flexible implant, eliminating the need for bone cutting or fusion.
Current position, sales performance and recent developments for Treace Medical, Xtant Medical and BONESUPPORT.
The platform transforms 2D C-arm fluoroscopic X-rays into navigable 3D volumes with 1mm cross-sectional slices, eliminating pre-operative CTs, MRIs, other scans or additional intraoperative imaging systems.
The capital will support Accelus’s continued commercial growth and further development of its differentiated spinal implant technologies.
Surgify Halo cuts bone while providing protective capabilities against incidental injuries to soft tissues.
The company grew in the mid-single-digits during its fiscal 2025 on the strength of its differentiated enabling technology.
A look at the opportunities and issues facing three orthopedic market regions: Europe, China and Latin America.
A primer on normalizing procedure demand, the changing basis of competition, shifting M&A trends and current international opportunities.
The company grew in the low double digits in 1Q25 on the strength of new product introductions and robust international sales.
Through the first four months of the year, orthopedic funding is off to its slowest start in the last decade.
The company grew in the mid-teens and could see even greater demand with MACI Arthro’s use for trochlea defects.
Insight’s EmbedMed platform digitizes the surgical planning process and allows for rapid design and manufacture of patient-specific guides for orthopedic surgery.
The company’s orthopedic sales declined about 10% in the first quarter of 2025, but its commercial channel showed ample promise.
The company grew in the low single digits for the first quarter of 2025 and expects accelerating growth through the year.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.